Leucocyte apheresis in the treatment of paediatric ulcerative colitis [1]

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 11, 2007, Pages 1390-1391

  Ruuska, Tarja ^a   Lähdeaho, Marja Leena ^a   Sutas, Yelda ^a   Ashorn, Merja ^a   Grönlund, Juhani ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; CYTOKINE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADOLESCENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG DOSE REDUCTION; FATIGUE; FEMALE; HEADACHE; HUMAN; LETTER; LEUKAPHERESIS; MALE; PEDIATRICS; PILOT STUDY; PRIORITY JOURNAL; RELAPSE; REMISSION; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; THERAPY RESISTANCE; TREATMENT DURATION; TREATMENT RESPONSE; ULCERATIVE COLITIS; WILCOXON SIGNED RANKS TEST;

ADOLESCENT; BLOOD COMPONENT REMOVAL; CHILD; COLITIS, ULCERATIVE; FEMALE; HUMANS; LEUKOCYTES; MALE; SEVERITY OF ILLNESS INDEX;

EID: 35148880818     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520701231116     Document Type: Letter

References (4)

1. Hyams J, Markowitz J, Lerer T, Griffiths A, Mack D, Bousvaros, et al. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol 2006;4:1118-23.
2. Siegel CA, Hur C, Korzenile JR, Gazelle GS, Sands BE. Risks and benefits of infliximab in the treatment of Crohn's disease. Clin Gastroenterol Hepatol 2006;4:1017-24.
3. Mahida YR. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis 2000;6:21-33.
4. Hanai H, Watanabe F, Takeuchi K, Iida T, Yamada M, Iwaoka Y, et al. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 2003;1:28-35.